Last $13.30 USD
Change Today +0.79 / 6.31%
Volume 938.8K
IRWD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Brian Stoltz Ph.D.

Scientific Advisor, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Brian Stoltz, Ph.D., serves as Scientific Advisor of Microbia, Inc. Dr. Stoltz is Associate Professor of chemistry at the California Institute of Technology. He is known internationally for the development of new strategies and tactics for the chemical synthesis of structurally complex molecules. Dr. Stoltz has received numerous awards for his teaching and research accomplishments, including the prestigious Presidential Early Career Award in Science and Engineering from ...

Read Full Background

Corporate Headquarters*

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRWD:US $13.30 USD +0.79

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$515.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRONWOOD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.